The ESA ISS Mission Update Everyone Is Talking About Today
During a live broadcast from the European Space Agency’s headquarters in Paris, Thomas Pesquet highlighted the urgency of extracting maximum scientific value from the ISS before its scheduled decommissioning in 2028. The ISS, a joint venture between NASA, Roscosmos, JAXA, ESA, and CSA, has been a laboratory in low Earth orbit for over two decades, yet many of its experiments remain underutilised. Pesquet, who spent 179 days aboard the station in 2018, argues that Europe’s investment in space science must translate into tangible research outcomes that benefit everyday life.
What Happened: Pesquet Calls for a Scientific Reckoning
At 10:00 a.m. CET, ESA’s Director of Science, Dr. Maria L. Sanchez, convened a briefing in the agency’s Paris headquarters to discuss the upcoming end-of-life plans for the ISS. Thomas Pesquet, the mission’s most recent French commander, delivered a 12‑minute address that was streamed to 1.2 million viewers worldwide. He cited that the station currently hosts 450 active experiments, of which only 120 have published peer‑reviewed results in the past year. Pesquet urged European governments to allocate an additional €120 million over the next four years to support the final phase of data collection, emphasising that the cost of a single experiment can be as low as €1.2 million but the potential societal impact is far greater. The briefing was recorded by ESA’s official channel and released under the Creative Commons licence, making it freely available for academic and public use.
Why It Matters: From Lab to Everyday Life
The ISS’s unique microgravity environment enables studies that cannot be replicated on Earth, from protein crystallisation that leads to new medicines to materials science that could improve battery life in electric vehicles. A higher scientific return translates directly into innovations that lower healthcare costs, increase energy efficiency, and create high‑skill jobs. Secondly, Europe’s space agenda is a matter of national pride and international influence. By under‑utilising the ISS, European agencies risk losing bargaining power in future collaborations, such as the Artemis program with NASA. Finally, public interest in space science is high; a demonstrable return on investment can secure continued funding from taxpayers and private partners alike. Without clear outcomes, the public may view space programmes as expensive experiments with little tangible benefit.
“Pesquet told reporters during the Paris briefing that 'Europe must not let its hard‑earned space expertise go to waste; every kilogram of data should answer a question that matters to humanity.'”
What We Don’t Know Yet: The Uncertainties of ISS Closure
While ESA has outlined a decommissioning schedule, the exact sequence of experiments to be prioritised remains unclear. There is no consensus on how many of the 450 active projects will be fully completed before 2028, nor on the distribution of funding across different scientific disciplines. The role of private sector partners, such as SpaceX and Blue Origin, in providing launch services for final experiments has not been formally negotiated. Additionally, the legal framework governing data ownership and access post‑closure is still under development, raising concerns about who will benefit from the research outputs. These gaps create uncertainty for researchers who rely on the ISS for long‑term studies and for policymakers tasked with allocating budgets in the coming fiscal years.
What to Watch: Upcoming Announcements and Funding Decisions
In the next 24 hours, ESA’s budget office is expected to release a draft proposal for the final funding tranche, which will be debated by the European Parliament’s Committee on Industry, Research and Energy. A press conference by ESA’s Director General, Dr. Jean‑Pierre Martin, is slated for 3 p.m. CET, where he may announce a partnership with the European Commission’s Horizon Europe programme. Meanwhile, NASA’s Administrator will likely address the ISS decommissioning timeline in a joint statement with ESA, clarifying launch vehicle commitments. Observers should monitor the European Space Agency’s official Twitter feed and the European Parliament’s website for real‑time updates, as these decisions will shape the scientific agenda for the last years of the ISS.
Despite being a microgravity lab, the ISS produces crystals up to 1000 times larger than those grown on Earth, dramatically improving drug‑design accuracy.
